Foamix Pharmaceuticals Ltd. Marketable Securities
Foamix Pharmaceuticals Ltd. had Marketable Securities of $16.68 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2020-03-12
- 2019-12-31: Marketable Securities $16.68M.
- 2019-09-30: Marketable Securities $15.76M.
- 2019-06-30: Marketable Securities $14.51M.
- 2019-03-31: Marketable Securities $39.53M.
| Period end | Marketable Securities |
|---|---|
| 2019-12-31 | $16.68M 10-K · filed 2020-03-12 |
| 2019-09-30 | $15.76M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $14.51M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $39.53M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $47.22M 10-K · filed 2020-03-12 |
| 2018-09-30 | $16.25M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $24.81M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $34.06M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $40.76M 10-K · filed 2019-02-28 |
| 2017-06-30 | $42.12M 6-K · filed 2017-08-08 |
| 2016-12-31 | $61.20M 10-K · filed 2018-03-01 |
| 2016-06-30 | $42.76M 6-K · filed 2016-08-10 |
| 2015-12-31 | $56.75M 20-F · filed 2017-02-21 |
| 2014-12-31 | $7.06M 20-F · filed 2016-03-02 |